These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7212947)

  • 21. Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry.
    Baruah S; Waziri R; Hegwood TS; Mallis LM
    Psychiatry Res; 1991 Jun; 37(3):261-70. PubMed ID: 1679949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antimalarial agents on plasma levels of chlorpromazine and its metabolites in schizophrenic patients.
    Makanjuola RO; Dixon PA; Oforah E
    Trop Geogr Med; 1988 Jan; 40(1):31-3. PubMed ID: 3381314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pimozide and chlorpromazine in acute schizophrenia.
    Pecknold JC; McClure DJ; Allan T; Wrzesinski L
    Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical reaction to L-dopa in schizophrenic patients.
    Alpert M; Friedhoff AJ; Marcos LR; Diamond F
    Am J Psychiatry; 1978 Nov; 135(11):1329-32. PubMed ID: 707630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of akinesia: plasma chlorpromazine and prolactin levels.
    Van Putten T; May PR; Wilkins JN
    Am J Psychiatry; 1980 Nov; 137(11):1446-8. PubMed ID: 7435684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia.
    Meng Q; Li R; Hou F; Zhang Q
    Clin Neurol Neurosurg; 2018 Feb; 165():134-138. PubMed ID: 29421173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M; Gouws E; Miller R; Moodley SV
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):77-82. PubMed ID: 10082231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
    Peet M; Middlemiss DN; Yates RA
    Br J Psychiatry; 1981 Aug; 139():112-7. PubMed ID: 7030443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of pattern of blood chlorpromazine and its metabolite levels and prediction of response to chlorpromazine treatment--studies on the rational pharmacotherapy in schizophrenics (author's transl)].
    Sakurai Y; Nakahara T; Ikenaga H; Takahashi R
    Seishin Shinkeigaku Zasshi; 1978 Jul; 80(7):405-24. PubMed ID: 724820
    [No Abstract]   [Full Text] [Related]  

  • 31. Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.
    Van Putten T; May PR
    Arch Gen Psychiatry; 1978 Apr; 35(4):477-80. PubMed ID: 727898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 34. A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
    Clark ML; Kaul PN
    Psychopharmacol Bull; 1975 Oct; 11(4):28-30. PubMed ID: 1105638
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level.
    Sakalis G; Curry SH; Mould GP; Lader MH
    Clin Pharmacol Ther; 1972; 13(6):931-46. PubMed ID: 5081606
    [No Abstract]   [Full Text] [Related]  

  • 36. Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.
    Ayers T; Liberman RP; Wallace CJ
    J Clin Psychopharmacol; 1984 Apr; 4(2):89-93. PubMed ID: 6707245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
    Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
    Sakalis G; Chan TL; Sathananthan G; Schooler N; Goldberg S; Gershon S
    Commun Psychopharmacol; 1977; 1(2):157-66. PubMed ID: 342185
    [No Abstract]   [Full Text] [Related]  

  • 40. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.